Доказательно о травах. Научный подход к фитотерапии

5. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, Johnson KC, LeBlanc E, Lee C, La Croix AZ, Park HL, Sims ST, Vitolins M, Wallace R. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women’s Health Initiative. Menopause. 2012 Sep;19(9):980-8. doi: 10.1097/gme.0b013e31824f606e. PMID: 22781782; PMCID: PMC3428489.

6. Hardcastle AC, Aucott L, Fraser WD, Reid DM, Macdonald HM. Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women. Eur J Clin Nutr. 2011 Mar;65(3):378-85. doi: 10.1038/ejcn.2010.264. Epub 2010 Dec 22. PMID: 21179049.

7. Monteleone, P., Mascagni, G., Giannini, A. et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol 14, 199–215 (2018). https://doi.org/10.1038/nrendo.2017.180

8. Gardner Z, McGuffin M, eds. American Herbal Products Association’s botanical safety handbook. Second ed. Boca Raton, FL: CRC Press; 2013.

9. Mansikkamäki K, Raitanen J, Malila N, Sarkeala T, Männistö S, Fredman J, Heinävaara S, Luoto R. Physical activity and menopause-related quality of life – a population-based cross-sectional study. Maturitas. 2015 Jan;80(1):69–74. doi: 10.1016/j.maturitas.2014.09.009. Epub 2014 Sep 30. PMID: 25449820.

10. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999 Spring;6(1):7-13. PMID: 10100174.

11. Gafner S. Black cohosh laboratory guidance documentexternal link disclaimer. 2015.

12. Chlebowski RT. Nutrition and physical activity influence on breast cancer incidence and outcome. Breast. 2013 Aug;22 Suppl 2:S30-7. doi: 10.1016/j.breast.2013.07.006. PMID: 24074789.

13. Betz JM, Anderson L, Avigan MI, Barnes J, Farnsworth NR, Gerdén B, et al. Black cohosh: considerations of safety and benefit. Nutr Today 2009;44:155-62.

14. Foster S. Black cohosh: a literature review. HerbalGram 1999;45:35–50.

15. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012:CD007244. [PubMed abstract]

16. Foster S. Exploring the peripatetic maze of black cohosh adulteration. HerbalGram 2013;May-July:32–51.

17. National Institutes of Health. Dietary Supplement Label Database. 2017.

18. Mills S, Bone K. Principles and practice of phytotherapy. Edinburgh: Churchill Livingstone; 2000.

19. Kruse SO, Lohning A, Pauli GF, Winterhoff H, Nahrstedt A. Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid.

20. Planta Med 1999;65:763-4. [PubMed abstract]

21. ConsumerLab.com. Product review: menopause supplements (soy and red clover isoflavones, black cohosh) and progesterone creamsexternal link disclaimer. 2016.

22. Schwabe North American, Incorporated. Remifemin®external link disclaimer.

23. Fabricant DS, Krause EC, Farnsworth NR. Black cohosh. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of dietary supplements. Second ed. New York: Informa Healthcare;2010:60–74.

24. Raus K, Brucker C, Gorkow C, Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 2006;13:678-91. [PubMed abstract]

25. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163-74. [PubMed abstract]

26. The North American Menopause Society. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 2015;22:1155-72. [PubMed abstract]

27. Borrelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci 2003;73:1215-29. [PubMed abstract]

28. Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, et al. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2003;44 Suppl 1:S9-20. [PubMed abstract]

29. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869-79. [PubMed abstract]

30. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-66. [PubMed abstract]

31. Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554-63. [PubMed abstract]

32. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol 2014;123:202-16. [PubMed abstract]